So, it has gotten better, but a lot of it also comes down to something that, Ben you mentioned, which is, as a patient, I have been pushed to the point where all of my providers are in the same health care system
Half of GLP-1 users told KFF the drugs are difficult to afford, and the brand-name versions have run past $1,000 a month at list price
Tocochromanols take a prolonged time (9-12 hours) from being consumed to entering the circulation in chylomicrons, a process that is promoted by a subsequent meal (15)
The CHIME model is the first validated tool for predicting outcomes in Chinese patients with prediabetes and type 2 diabetes, developed using Chinese data
Thats meant the drugs which can cost upwards of $1,000 monthly have been largely unaffordable for many